Tax-driven share sales by Invivyd (IVVD) CFO after RSU vesting
Rhea-AI Filing Summary
Invivyd, Inc. Chief Financial Officer William E. Duke reported a mix of RSU vesting and related share sales. On February 15, 2026, he acquired 99,000 shares of common stock at no cost through the exercise of restricted stock units, leaving him with 148,344 shares.
On February 17 and 18, 2026, he sold 19,663 shares at a weighted average price of $1.5396 and 20,964 shares at a weighted average price of $1.5778 in open-market transactions. The company notes these were non-discretionary “sell-to-cover” sales to satisfy tax withholding obligations under a Rule 10b5-1 plan, and 107,717 shares of common stock remained held directly afterward.
Positive
- None.
Negative
- None.
Insights
Mixed insider activity driven mainly by RSU vesting and tax withholding.
The Invivyd Chief Financial Officer exercised 99,000 restricted stock units on February 15, 2026, receiving an equivalent number of common shares at a price of $0.0000 per share. This reflects equity compensation vesting rather than an open-market purchase.
Subsequently, he sold 19,663 shares at a weighted average of $1.5396 on February 17, 2026 and 20,964 shares at a weighted average of $1.5778 on February 18, 2026. Footnotes specify these were non-discretionary “sell-to-cover” transactions to satisfy tax withholding obligations under a Rule 10b5-1 plan.
After these trades, the officer directly held 107,717 common shares. Because the sales are tied to tax obligations and a pre-established trading plan, they are typically viewed as more routine and less indicative of a change in sentiment than discretionary insider selling. The net effect is a 40,627-share reduction in holdings alongside ongoing RSU vesting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,964 | $1.5778 | $33K |
| Sale | Common Stock | 19,663 | $1.5396 | $30K |
| Exercise | Restricted Stock Units | 99,000 | $0.00 | -- |
| Exercise | Common Stock | 99,000 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company"). The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
